» Articles » PMID: 34135603

Prevalence and Associated Factors of Methicillin Resistance (MRSA) Among Urinary Tract Infection Suspected Patients Attending at Arba Minch General Hospital, Southern Ethiopia

Overview
Publisher Dove Medical Press
Date 2021 Jun 17
PMID 34135603
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Urinary tract infection (UTI) is a very frequent infection both in the community and hospital patients, and the emergence of methicillin-resistant (MRSA) in the community setting and infections with this pathogen become a prevalent problem among UTI patients. Therefore, the aim of this study was to determine prevalence and associated factors of methicillin resistance (MRSA) among urinary tract infection suspected patients attending at Arba Minch General Hospital.

Methods: Facility-based cross-sectional study was done at Arba Minch General Hospital from July to October 2020. Midstream urine specimen was collected from outpatients, cultured and biochemical tests were performed to identify the intended pathogen, finally the antibiotic susceptibility pattern of MRSA was done and possible associated factors were determined. The cleaned data were entered and analyzed using SPSS version 21.

Results: Four hundred and twenty two (422) adult outpatients were enrolled in this study, of which males accounted for 238 (56.4%) of the participants. The mean and standard deviation age of the participants was 27.4 (SD 27.4 ± 15.6) years. A total of 54 isolates were recovered from urine specimen. The prevalence of MRSA among the isolated was 23/54 (42.59% (95% CI (35.0, 47.0)). Participants who had previous exposure to UTI (p < 0.002), presence of chronic disease (p < 0.029), and hospitalization (p < 0.006) were statically associated with the prevalence of MRSA. From all the MRSA isolates, 53.7% were resistant against Nitrofurantoin.

Conclusion: This study revealed that MRSA could be prevalent in isolates from patients suspected of urinary tract infection and exhibiting different resistance pattern for antibiotics commonly used for treatment of staphylococcal infections.

Citing Articles

for targeting MRSA virulence: and studies.

Rawas S, Al Hakawati N, Mcheik A, El S El Badan D Heliyon. 2025; 11(1):e41536.

PMID: 39850410 PMC: 11754165. DOI: 10.1016/j.heliyon.2024.e41536.


Efficacy and clinical potential of phage therapy in treating methicillin-resistant Staphylococcus aureus (MRSA) infections: A review.

Fortaleza J, Ong C, De Jesus R Eur J Microbiol Immunol (Bp). 2024; 14(1):13-25.

PMID: 38305804 PMC: 10895361. DOI: 10.1556/1886.2023.00064.


The outbreak of migratory goat's brucellosis in the Swat ecosystem of Khyber Pakhtunkhwa.

Qayum N, Uddin M, Khan W, Nabi H, Din T, Suleman M Onderstepoort J Vet Res. 2023; 90(1):e1-e9.

PMID: 37916704 PMC: 10623478. DOI: 10.4102/ojvr.v90i1.2079.


Niosome as an Effective Nanoscale Solution for the Treatment of Microbial Infections.

Barani M, Paknia F, Roostaee M, Kavyani B, Kalantar-Neyestanaki D, Ajalli N Biomed Res Int. 2023; 2023:9933283.

PMID: 37621700 PMC: 10447041. DOI: 10.1155/2023/9933283.


Magnitude and associated factors of bacterial urinary tract infections among paediatric patients in Arba Minch, southern Ethiopia.

Elale A, Manilal A, Tadesse D, Seid M, Dubale A New Microbes New Infect. 2023; 51:101083.

PMID: 36691648 PMC: 9860381. DOI: 10.1016/j.nmni.2023.101083.

References
1.
Rahimi F, Katouli M, Karimi S . Biofilm production among methicillin resistant Staphylococcus aureus strains isolated from catheterized patients with urinary tract infection. Microb Pathog. 2016; 98:69-76. DOI: 10.1016/j.micpath.2016.06.031. View

2.
Shahmoradi M, Faridifar P, Shapouri R, Mousavi S, Ezzedin M, Mirzaei B . Determining the Biofilm Forming Gene Profile of Clinical Isolates via Multiplex Colony PCR Method. Rep Biochem Mol Biol. 2019; 7(2):181-188. PMC: 6374067. View

3.
Humphries R, Abbott A, Hindler J . Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories. J Clin Microbiol. 2019; 57(6). PMC: 6535595. DOI: 10.1128/JCM.00203-19. View

4.
Said-Salim B, Mathema B, Kreiswirth B . Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen. Infect Control Hosp Epidemiol. 2003; 24(6):451-5. DOI: 10.1086/502231. View

5.
Looney A, Redmond E, Davey N, Daly P, Troy C, Carey B . Methicillin-resistant Staphylococcus aureus as a uropathogen in an Irish setting. Medicine (Baltimore). 2017; 96(14):e4635. PMC: 5411178. DOI: 10.1097/MD.0000000000004635. View